Tiba ya Hemophilia A Gene, AMT-180, Inaendelea Kuonyesha Shughuli, Usalama katika Wanyama

Tiba ya Hemophilia A Gene, AMT-180, Inaendelea Kuonyesha Shughuli, Usalama katika Wanyama

Habari za Hemophilia Leo

Image

Please enable the javascript to submit this form

Inafadhiliwa na ruzuku za elimu kutoka Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, na uniQure, Inc.

SSL muhimu